Author
Listed:
- Angélica María Sabogal-Guáqueta
(University of Groningen)
- Alejandro Marmolejo-Garza
(University of Groningen
University of Groningen, University Medical Center Groningen)
- Marina Trombetta-Lima
(University of Groningen
University of Groningen, University Medical Center Groningen)
- Asmaa Oun
(University of Groningen)
- Jasmijn Hunneman
(University of Groningen)
- Tingting Chen
(University of Groningen)
- Jari Koistinaho
(University of Eastern Finland
University of Helsinki)
- Sarka Lehtonen
(University of Eastern Finland)
- Arjan Kortholt
(University of Groningen
YETEM-Innovative Technologies Application and Research Centre Suleyman Demirel University)
- Justina C. Wolters
(University of Groningen, University Medical Center Groningen)
- Barbara M. Bakker
(University of Groningen, University Medical Center Groningen)
- Bart J. L. Eggen
(University of Groningen, University Medical Center Groningen)
- Erik Boddeke
(University of Groningen, University Medical Center Groningen)
- Amalia Dolga
(University of Groningen)
Abstract
Metabolic reprogramming is a hallmark of the immune cells in response to inflammatory stimuli. This metabolic process involves a switch from oxidative phosphorylation (OXPHOS) to glycolysis or alterations in other metabolic pathways. However, most of the experimental findings have been acquired in murine immune cells, and little is known about the metabolic reprogramming of human microglia. In this study, we investigate the transcriptomic, proteomic, and metabolic profiles of mouse and iPSC-derived human microglia challenged with the TLR4 agonist LPS. We demonstrate that both species display a metabolic shift and an overall increased glycolytic gene signature in response to LPS treatment. The metabolic reprogramming is characterized by the upregulation of hexokinases in mouse microglia and phosphofructokinases in human microglia. This study provides a direct comparison of metabolism between mouse and human microglia, highlighting the species-specific pathways involved in immunometabolism and the importance of considering these differences in translational research.
Suggested Citation
Angélica María Sabogal-Guáqueta & Alejandro Marmolejo-Garza & Marina Trombetta-Lima & Asmaa Oun & Jasmijn Hunneman & Tingting Chen & Jari Koistinaho & Sarka Lehtonen & Arjan Kortholt & Justina C. Wolt, 2023.
"Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction,"
Nature Communications, Nature, vol. 14(1), pages 1-24, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42096-7
DOI: 10.1038/s41467-023-42096-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42096-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.